Julie Lang

19PUBLICATIONS
96CO-AUTHORS
Liquid biopsiesMicroelectromechanical systems (MEMS)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 29, 2026
The Past, Present, and Future of Sentinel Lymph Node Biopsy in Breast Cancer.

|May 28, 2025
Mechanical Conditioning (MeCo) Score Progressively Increases Through the Metastatic Cascade in Breast Cancer via Circulating Tumor Cells.

|Jan 21, 2025
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer.

Rahat Alam, Anna Reva, David G Edwards

|Oct 22, 2024
Real-World Outcomes with the KEYNOTE-522 Regimen in Early-Stage Triple-Negative Breast Cancer.

Casey Connors, Stephanie A Valente, Ayat ElSherif

|Feb 10, 2024
Integrated Proteogenomic Analysis Reveals Distinct Potentially Actionable Therapeutic Vulnerabilities in Triple-Negative Breast Cancer Subtypes.

Pushpinder Kaur, Alexander Ring, Tania B Porras

|Dec 21, 2023
Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial.

Monica N Khattak, Anna M Chichura, Julie E Lang

Pageof 4

Frequent Collaborators

4 joint publications

Gillian L Hirst

4 joint publications

Debu Tripathy

3 joint publications

Hope S Rugo

3 joint publications

Lamorna Brown-Swigart